The Union Health Ministry has sought strict compliance from all drug manufacturers, in line with the revised Schedule M norms for pharmaceutical products in India. Licences of non-compliant units would be cancelled, the Ministry has warned.

The direction comes after an emergency meeting with all States and Union Territories on Sunday (October 5, 2025) evening, following a report by the Tamil Nadu Drugs Control Department, which found above permissible levels of diethylene glycol (DEG) in samples of Coldrif, a cough syrup brand.

Testing of cough syrup brands was initiated following the death of more than 10 children in Rajasthan and Madhya Pradesh recently.

Preliminary findings in past week have ruled out common infectious diseases, except for one positive case of leptospirosis. Ninete

See Full Page